Quantinno Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $65.3M | Buy |
2,712,410
+856,584
| +46% | +$22.4M | 0.08% | 290 |
|
|
2026
Q1 | $52.1M | Buy |
1,855,826
+175,560
| +10% | +$4.67M | 0.09% | 263 |
|
|
2025
Q4 | $41.8M | Buy |
1,680,266
+42,820
| +3% | +$1.08M | 0.08% | 261 |
|
|
2025
Q3 | $41.7M | Buy |
1,637,446
+684,298
| +72% | +$16.9M | 0.11% | 178 |
|
|
2025
Q2 | $23.1M | Buy |
953,148
+355,007
| +59% | +$8.28M | 0.1% | 219 |
|
|
2025
Q1 | $15.2M | Buy |
598,141
+203,862
| +52% | +$5.33M | 0.1% | 227 |
|
|
2024
Q4 | $10.5M | Buy |
394,279
+24,490
| +7% | +$664K | 0.1% | 196 |
|
|
2024
Q3 | $10.7M | Buy |
369,789
+89,835
| +32% | +$2.62M | 0.14% | 122 |
|
|
2024
Q2 | $7.83M | Buy |
279,954
+436
| +0.2% | +$12K | 0.14% | 117 |
|
|
2024
Q1 | $7.76M | Buy |
279,518
+217,294
| +349% | +$6.03M | 0.17% | 108 |
|
|
2023
Q4 | $1.79M | Sell |
62,224
-51,437
| -45% | -$1.55M | 0.06% | 424 |
|
|
2023
Q3 | $3.77M | Sell |
113,661
-109,432
| -49% | -$3.87M | 0.17% | 109 |
|
|
2023
Q2 | $8.18M | Buy |
223,093
+25,461
| +13% | +$991K | 0.47% | 29 |
|
|
2023
Q1 | $8.06M | Buy |
197,632
+65,028
| +49% | +$2.81M | 0.53% | 21 |
|
|
2022
Q4 | $6.79M | Buy |
132,604
+56,729
| +75% | +$2.72M | 0.51% | 25 |
|
|
2022
Q3 | $3.32M | Buy |
75,875
+4,661
| +7% | +$226K | 0.43% | 29 |
|
|
2022
Q2 | $3.73M | Buy |
71,214
+11,177
| +19% | +$570K | 0.54% | 21 |
|
|
2022
Q1 | $3.11M | Buy |
60,037
+3,930
| +7% | +$204K | 0.47% | 33 |
|
|
2021
Q4 | $3.31M | Buy |
+56,107
| New | +$2.78M | 0.6% | 25 |
|
|
2021
Q1 | – | Sell |
-9,401
| Closed | -$346K | – | 306 |
|
|
2020
Q4 | $346K | Sell |
9,401
-508
| -5% | -$18.6K | 0.27% | 183 |
|
|
2020
Q3 | $345K | Buy |
9,909
+1,222
| +14% | +$42.8K | 0.23% | 224 |
|
|
2020
Q2 | $270K | Buy |
+8,687
| New | +$295K | 0.27% | 191 |
|
|
2020
Q1 | – | Sell |
-21,679
| Closed | -$806K | – | 505 |
|
|
2019
Q4 | $806K | Buy |
+21,679
| New | +$772K | 0.51% | 2 |
|
|
2019
Q3 | – | Sell |
-13,196
| Closed | -$542K | – | 484 |
|
|
2019
Q2 | $542K | Buy |
+13,196
| New | +$524K | 0.32% | 83 |
|
|
2019
Q1 | – | Sell |
-10,375
| Closed | -$430K | – | 445 |
|
|
2018
Q4 | $430K | Buy |
+10,375
| New | +$431K | 0.35% | 89 |
|
Other funds holding PFE
Quantinno Capital Management's PFE Position: Q2 2026 in Review
Quantinno Capital Management increased its Pfizer (PFE) stake by 46% in Q2 2026, buying an estimated $22.4M and bringing the position to 2,712,410 shares worth $65.3M. The position accounts for 0.08% of the portfolio, ranked #290.
Quantinno Capital Management first reported a position in PFE in Q4 2018 and has held it in 25 quarters since. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Quantinno Capital Management held 2,712,410 shares of Pfizer worth $65.3M as of Q2 2026.
- Quantinno Capital Management bought 856,584 Pfizer shares in Q2 2026, an estimated $22.4M.
- Pfizer made up 0.08% of Quantinno Capital Management's portfolio in Q2 2026, its #290 holding.
- Quantinno Capital Management first reported a position in Pfizer in Q4 2018 and has held it in 25 quarters since.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.